NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE270887 Query DataSets for GSE270887
Status Public on Sep 16, 2024
Title Toggling of BRD4 functions is triggered through its phosphorylation by JNK [RNAseq-JQ1]
Organism Homo sapiens
Experiment type Expression profiling by high throughput sequencing
Summary BRD4 is a key regulatory factor in multiple cancers and cellular stress responses with pleotropic functions. It regulates chromatin remodeling and transcription through its histone acetyltransferase (HAT) and kinase activities, respectively. The mechanism responsible for switching BRD4 from a chromatin to transcriptional regulator is currently unknown. Here, we report that in response to a broad range of stimuli, this switch is mediated by the JNK kinase which directly interacts with BRD4. JNK specifically phosphorylates human BRD4 at Thr1186 and Thr1212, triggering transient BRD4 release from chromatin. JNK phosphorylation of BRD4 halts its HAT-mediated chromatin regulation and activates its transcription-enhancing kinase function. BRD4 release from chromatin is necessary to toggle between its enzymatic activities: chromatin-bound BRD4 is kinase inactive and RNA Pol II-bound BRD4 does not acetylate chromatin. BRD4 release from chromatin augments its interaction with and phosphorylation of key transcriptional regulators RNA Pol II, PTEFb and c-MYC. The PP4 phosphatase dephosphorylates JNK phosphorylated BRD4 in the nucleoplasm, which promotes its interaction with RNA Pol II at transcriptionally active sites. Accordingly, JNK-mediated release of BRD4 from chromatin leads to significantly elevated transcription of BRD4-regulated immune and inflammatory response genes through enhanced BRD4-Pol II interaction at the promoters of these genes. JNK phosphorylation of BRD4 occurs during T-cell activation and is required for epithelial to mesenchymal transition (EMT) in prostate cancer cells. These findings thus characterize a novel mechanism that triggers the transition of BRD4 from a chromatin regulator to transcriptional activator during stress/immune/inflammatory responses and EMT.
 
Overall design This RNA-seq analysis is aimed at identifying genome-wide differential gene expression when HCT116 cells are treated JQ1, a small molecule BET inhibitor that blocks BRD4 from binding chromatin. The analysis includes samples where untransfected (E) and wild type BRD4 transfected (B) HCT116 cells are treated with or without 500nM JQ1 (J) for 18 hrs. The analysis was done to compare the DEGs from JQ1 treated cells with the DEGs identified upon the release of BRD4 from chromatin through JNK activiation.
 
Contributor(s) Ballachanda DN, Singh AK, Mu J, Chen Q, Meerzaman D, Singer D
Citation missing Has this study been published? Please login to update or notify GEO.
Submission date Jun 26, 2024
Last update date Sep 16, 2024
Contact name Dinah S. Singer
E-mail(s) dinah.singer@nih.gov
Phone 301-496-9097
Organization name National Cancer Institute
Department Division of Cancer Biology
Street address Building 10, Room 4B-17
City Bethesda
State/province MD
ZIP/Postal code 20892
Country USA
 
Platforms (1)
GPL24676 Illumina NovaSeq 6000 (Homo sapiens)
Samples (12)
GSM8354205 Control empty vector transfected cells, biol HCT116 rep1
GSM8354206 Control empty vector transfected cells, biol HCT116 rep2
GSM8354207 Control empty vector transfected cells, biol HCT116 rep3
This SubSeries is part of SuperSeries:
GSE252982 Toggling of BRD4 functions is triggered through its phosphorylation by JNK.
Relations
BioProject PRJNA1128696

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE270887_RAW.tar 1.3 Mb (http)(custom) TAR (of TSV)
SRA Run SelectorHelp
Raw data are available in SRA

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap